Results 331 to 340 of about 653,031 (357)
Some of the next articles are maybe not open access.
Rational, biologically based treatment of EGFR-mutant non-small-cell lung cancer
Nature Reviews Cancer, 2010William Pao
exaly
Understanding resistance to EGFR inhibitors—impact on future treatment strategies
Nature Reviews Clinical Oncology, 2010Deric L Wheeler, Paul M Harari
exaly
Making the first move in EGFR-driven or ALK-driven NSCLC: first-generation or next-generation TKI?
Nature Reviews Clinical Oncology, 2018Gonzalo Recondo +2 more
exaly
Nuclear PKM2 regulates β-catenin transactivation upon EGFR activation
Nature, 2011Weiwei Yang, , Zhimin Lu
exaly
Targeting EGFR exon 20 insertion mutations in non-small cell lung cancer
Signal Transduction and Targeted Therapy, 2019Simon Vyse, Paul H Huang
exaly

